REG - Cirata PLC - DevOps Final Consideration Received

CirataAnnouncement

Yesterday 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251219:nRSS3463Ma&default-theme=true

RNS Number : 3463M  Cirata PLC  19 December 2025

 19 December 2025

Cirata plc

("Cirata" or the "Company")

DevOps Final Consideration Received

Cirata plc (LSE: CRTA) is pleased to announce that, further to the completion
of the divestment of its DevOps assets (the "Transaction") to BlueOptima, as
disclosed on 15 July 2025, the Company has received a final consideration
payment of US$900,000 from BlueOptima.

Following receipt of the final consideration payment, no further amounts
remain payable to the Company in connection with the Transaction.

 

For further information, please contact:

 Cirata                                     Via FTI Consulting
 Stephen Kelly, Chief Executive Officer
 Ricardo Moura, Chief Financial Officer
 Dan Hayes, Investor Relations

 FTI Consulting                             +44 (0) 20 3727 1137
 Matt Dixon / Kwaku Aning / Usama Ali

 Stifel (Nomad and Joint Broker)            +44 (0) 20 7710 7600
 Fred Walsh / Brough Ransom / Ben Good

 Panmure Liberum (Joint Broker)             +44 (0) 20 3100 2000
 Rupert Dearden / John More

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBSBDDCSBDGUC



            Copyright 2019 Regulatory News Service, all rights reserved